Novartis (NVS) Earnings Date, Estimates & Call Transcripts → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free NVS Stock Alerts $94.37 +1.80 (+1.94%) (As of 04/19/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateApr. 23EstimatedActual EPS (Jan. 30) $1.53 Missed By -$0.11 Consensus EPS (Jan. 30) $1.64 Read Call TranscriptListen to Call Get Novartis Earnings AlertsEnter your email address below to receive the latest news and earnings results for NVS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNVS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NVS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Novartis Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$1.71$1.71$1.71 Q2 20241$1.78$1.78$1.78 Q3 20241$1.83$1.83$1.83 Q4 20241$1.77$1.77$1.77 FY 20244$7.09$7.09$7.09 Q1 20251$1.92$1.92$1.92 Q2 20251$2.00$2.00$2.00 Q3 20251$1.99$1.99$1.99 Q4 20251$1.90$1.90$1.90 FY 20254$7.81$7.81 $7.81NVS Earnings Date and InformationNovartis last released its earnings results on January 30th, 2024. The reported $1.53 earnings per share for the quarter, missing analysts' consensus estimates of $1.64 by $0.11. The firm had revenue of $11.42 billion for the quarter, compared to analyst estimates of $11.69 billion. Novartis has generated $7.18 earnings per share over the last year ($7.18 diluted earnings per share) and currently has a price-to-earnings ratio of 13.1. Earnings for Novartis are expected to grow by 11.47% in the coming year, from $7.15 to $7.97 per share. Novartis has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 23rd, 2024 based off prior year's report dates.Read More Novartis Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 4/23/2024Estimated)------- 1/30/2024Q4 2023$1.64$1.53($0.11)($1.08)$11.69 billion$11.42 billion 10/23/2023Q3 2023$1.70$1.74+$0.04$2.63$12.05 billion$11.78 billion 7/19/2023Q2 2023$1.68$1.83+$0.15$2.55$6.32 million$13.62 billion 4/25/2023Q1 2023$1.55$1.71+$0.16$2.34$12.60 billion$12.95 billion 2/1/2023Q4 2022$1.42$1.51+$0.09$2.34$12.85 billion$12.69 billion10/25/2022Q3 2022$1.57$1.58+$0.01$2.44$12.90 billion$12.54 billion Get the Latest News and Ratings for NVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novartis and its competitors with MarketBeat's FREE daily newsletter. 7/19/2022Q2 2022$1.51$1.56+$0.05$2.35$12.78 billion$12.78 billion 4/26/2022Q1 2022$1.44$1.46+$0.02$1.92$12.61 billion$12.53 billion 2/2/2022Q4 2021$1.44$1.40($0.04)($4.44)$13.25 billion$13.23 billion 10/25/2021Q3 2021$1.65$1.71+$0.06$2.20$13.02 billion$13.03 billion 7/20/2021Q2 2021$1.52$1.66+$0.14$2.00$12.41 billion$12.96 billion 4/26/2021Q1 2021$1.54$1.52($0.02)$2.13$12.63 billion$12.41 billion Novartis Earnings - Frequently Asked Questions When is Novartis's earnings date? Novartis has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, April 23rd, 2024 based off last year's report dates. Learn more on NVS's earnings history. Did Novartis beat their earnings estimates last quarter? In the previous quarter, Novartis (NYSE:NVS) missed the analysts' consensus estimate of $1.64 by $0.11 with a reported earnings per share (EPS) of $1.53. Learn more on analysts' earnings estimate vs. NVS's actual earnings. How can I listen to Novartis's earnings conference call? The conference call for Novartis's latest earnings report can be listened to online. Listen to Conference Call How can I read Novartis's conference call transcript? The conference call transcript for Novartis's latest earnings report can be read online. Read Transcript How much revenue does Novartis generate each year? Novartis (NYSE:NVS) has a recorded annual revenue of $45.44 billion. How much profit does Novartis generate each year? Novartis (NYSE:NVS) has a recorded net income of $14.85 billion. NVS has generated $7.18 earnings per share over the last four quarters. What is Novartis's price-to-earnings ratio? Novartis (NYSE:NVS) has a trailing price-to-earnings ratio of 13.14 and a forward price-to-earnings ratio of 13.20. The price/earnings-to-growth ratio is 1.45. What is Novartis's EPS forecast for next year? Novartis's earnings are expected to grow from $7.15 per share to $7.97 per share in the next year, which is a 11.47% increase. More Earnings Resources from MarketBeat Related Companies: Abbott Laboratories Earnings Date AstraZeneca Earnings Date Pfizer Earnings Date Sanofi Earnings Date AbbVie Earnings Date Bristol-Myers Squibb Earnings Date Vertex Pharmaceuticals Earnings Date Regeneron Pharmaceuticals Earnings Date Merck & Co., Inc. Earnings Date GSK Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Taiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later? This page (NYSE:NVS) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTISHOCKING Crypto Leak…Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceOptions trading has suddenly become more reliable.Eagle PublishingHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novartis AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.